Health Catalyst (HCAT) Misses Q2 EPS by 58c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts HCAT Hot Sheet
Join SI Premium – FREE
Health Catalyst (NASDAQ: HCAT) reported Q2 EPS of ($0.55), $0.58 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $70.4 million versus the consensus estimate of $68.97 million.
For earnings history and earnings-related data on Health Catalyst (HCAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Western Union (WU) Tops Q3 EPS by 8c; offers guidance
- Xperi Corporation (XPER) Tops Q3 EPS by 3c; Offers Guidance
- ZoomInfo Technologies Inc. (GTM) Reports In-Line Q3 EPS; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
